Related Experiment Video
Updated: Sep 13, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
microRNA-1-3p and T-synthase mRNA have high diagnostic efficacy on intestinal mucosal barrier dysfunction in patients
Wen-Bo Wu1, Xiao-Fei Jiang1, Ming-Quan Chen1
1Department of Emergency Medicine, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Abstract:
Acute pancreatitis (AP) is an inflammatory disorder of the pancreas that can be complicated by intestinal mucosal barrier dysfunction (SAP&IBD). The current study sought to examine the diagnostic efficacy of miR-1-3p and T-synthase mRNA in SAP&IBD patients. First, SAP patients were assigned to SAP&IBD and SAP groups. Serum miR-1-3p expression and T-synthase mRNA expression patterns in peripheral blood B lymphocytes were measured using RT-qPCR. Pearson tests, ROC curve analysis, and multivariate logistic regression were used to analyze the correlation between miR-1-3p/T-synthase mRNA and clinical data, their diagnostic efficiency, and independent risk factors for SAP&IBD patients, respectively. The results showed that serum miR-1-3p in the SAP&IBD group was elevated, and T-synthase mRNA expression in peripheral blood B lymphocytes was diminished. Additionally, serum miR-1-3p expression in SAP&IBD patients was negatively correlated with T-synthase mRNA expression, and positively correlated with their Ranson score, CRP, IL-6, DAO, and D-Lactate levels. Meanwhile, T-synthase mRNA level was negatively correlated with IL-6, DAO, and D-Lactate levels. Both, serum miR-1-3p, T-synthase mRNA, and their combination were found to exhibit diagnostic efficiency for SAP&IBD patients, and were independently associated with IBD in SAP patients. Collectively, our findings suggest that miR-1-3p and T-synthase serve as independent risk factors for SAP&IBD patients and can aid the diagnosis of IBD in SAP patients.
Insights
This study found that elevated miR-1-3p and decreased T-synthase mRNA can help diagnose intestinal mucosal barrier dysfunction in severe acute pancreatitis (SAP&IBD) patients. These biomarkers are independent risk factors for SAP&IBD.
Area of Science:
- Gastroenterology and Molecular Biology
- Biomarker Discovery
- Pancreatic Diseases
Background:
- Severe acute pancreatitis (SAP) can lead to intestinal mucosal barrier dysfunction (SAP&IBD), a serious complication.
- Effective diagnostic markers for SAP&IBD are crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To evaluate the diagnostic efficacy of serum miR-1-3p and T-synthase mRNA in peripheral blood B lymphocytes for identifying SAP&IBD.
- To investigate the correlation between these biomarkers and clinical indicators of inflammation and intestinal damage.
Main Methods:
- Serum miR-1-3p and T-synthase mRNA expression were measured in SAP patients with and without intestinal barrier dysfunction using RT-qPCR.
- Statistical analyses included Pearson correlation, ROC curve analysis, and multivariate logistic regression.
Main Results:
- SAP&IBD patients exhibited significantly higher serum miR-1-3p levels and lower T-synthase mRNA expression compared to SAP patients.
- Serum miR-1-3p showed a negative correlation with T-synthase mRNA and positive correlations with Ranson score, CRP, IL-6, DAO, and D-Lactate.
- T-synthase mRNA levels were negatively correlated with IL-6, DAO, and D-Lactate.
- Both miR-1-3p and T-synthase mRNA, individually and in combination, demonstrated diagnostic efficiency for SAP&IBD.
Conclusions:
- Serum miR-1-3p and T-synthase mRNA are valuable diagnostic biomarkers for intestinal mucosal barrier dysfunction in severe acute pancreatitis.
- These biomarkers serve as independent risk factors and can aid in the diagnosis of IBD in SAP patients.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology